TÜRKÇE
ENGLISH
Information
| Unit | FACULTY OF PHARMACY |
| PHARMACY PR. | |
| Code | ECF303 |
| Name | Pharmaceutical Chemistry II |
| Term | 2019-2020 Academic Year |
| Semester | 5. Semester |
| Duration (T+A) | 2-0 (T-A) (17 Week) |
| ECTS | 4 ECTS |
| National Credit | 2 National Credit |
| Teaching Language | Türkçe |
| Level | Lisans Dersi |
| Type | Normal |
| Label | C Compulsory |
| Mode of study | Yüz Yüze Öğretim |
| Catalog Information Coordinator | Dr. Öğr. Üyesi ÖZDEN TARI |
| Course Instructor |
Dr. Öğr. Üyesi ÖZDEN TARI
(Güz)
(A Group)
(Ins. in Charge)
|
Course Goal / Objective
The purpose of this course is to give a basic concept on general features, mode of action, structure-activity relationship, synthesis and biotransformation of the drugs affecting on autonomic nerveous system and cardiovascular system.
Course Content
Adrenergic agents, adrenergic blocking agents, cholinergic agents, cholinergic blocking agents, cardiac glycosides, antiarrhythmics, antianginal and vasodilatory agents, antihypertensives, antihyperlipidemics, coagulant and anticoagulant agents, antianemic drugs, trombolytics, antiaggregan agents and diuretics.
Course Precondition
Resources
Notes
Course Learning Outcomes
| Order | Course Learning Outcomes |
|---|---|
| LO01 | The student who completes this course learn autonomic nerveous system drugs; analeptic, adrenergic, adrenergic blocking, cholinergic, cholinergic blocking agents |
| LO02 | The student who completes this course learn basic concept on general features, mode of action, structure-activity relationship, synthesis of autonomic nerveous system drugs. |
| LO03 | The student who completes this course learn biotransformation of autonomic nerveous system drugs. |
| LO04 | The student who completes this course learn cardiovascular system drugs. |
| LO05 | The student who completes this course learn mode of action, structure-activity relationship, synthesis and biotransformation of cardiovascular system drug. |
Relation with Program Learning Outcome
| Order | Type | Program Learning Outcomes | Level |
|---|---|---|---|
| PLO01 | - | Have sufficient knowledge in pharmaceutical field and develop the knowledge gained. | 5 |
| PLO02 | - | Applies the profession in accordance with the existing laws and regulations,gains awareness of professional and ethical responsibility. | 2 |
| PLO03 | - | It serves the society as a pharmacist who is loyal to Atatürk's principles and reforms, equipped with Universal Knowledge, who uses Turkish correctly and knows at least one foreign language. | 0 |
| PLO04 | - | Communicates effectively both orally and in writing. | 2 |
| PLO05 | - | External appearance, attitude, attitude and behavior, with professional identity, role model and society becomes an example to colleagues. | 1 |
| PLO06 | - | Provides consultancy services to patients, community and health care personnel with a wide range of information on the drug,evaluates advanced knowledge and skills with a critical approach. | 5 |
| PLO07 | - | Possessing the knowledge of historical and current developments in the field of Pharmacy, monitoring, evaluation and application of scientific and evidence-based data, and adopting lifelong learning. | 5 |
| PLO08 | - | Have knowledge about health policies and health economics, pharmacy management and define the problems in pharmaceutical field. | 2 |
| PLO09 | - | Interprets information about current health and treatment problems. Plays an active role in community health. | 4 |
| PLO10 | - | Pharmacy integrates and develops professional knowledge with information from different disciplines and uses the acquired knowledge to improve the health level and quality of life of the community. | 5 |
| PLO11 | - | Students will be able to use the concepts and applications of basic sciences and basic medical sciences effectively in the field of Medicine and pharmacy and have the experience of working with these health sciences. | 2 |
| PLO12 | - | Acquires basic information about diseases, adopts and applies rational drug use on all drugs that affect systems. | 4 |
| PLO13 | - | By learning the basics of Clinical Pharmacy,will have the knowledge and skills to help provide drug/patient oriented pharmacy applications and individualized Pharmaceutical Care. | 1 |
| PLO14 | - | It plays a role in the evaluation and analysis of the events and cases related to the development of pharmacy profession and education. | 3 |
Week Plan
| Week | Topic | Preparation | Methods |
|---|---|---|---|
| 1 | Analeptic and adrenergic drugs | Textbooks | |
| 2 | Adrenergic blockers | Textbooks | |
| 3 | Cholinergic drugs | Textbooks | |
| 4 | Cholinergic blockers | Textbooks | |
| 5 | Cardiovascular drugs, drug for the treatment of congestive heart filure | Textbooks | |
| 6 | Antiarrhytmicdrugs | Textbooks | |
| 7 | Antianginal drugs, periferic vasodilator drugs | Textbooks | |
| 8 | Mid-Term Exam | Textbooks | |
| 9 | Antihypertensive drugs | Textbooks | |
| 10 | Diuretic drugs | Textbooks | |
| 11 | Electrolytes and acide-base regulators | Textbooks | |
| 12 | Antihyperlipidemic drugs | Textbooks | |
| 13 | Hemostatic and anticoagulant drugs | Textbooks | |
| 14 | Antitrobocyte and trombolytic drugs | Textbooks | |
| 15 | Antianemic drugs | Textbooks | |
| 16 | Term Exams | Textbooks | |
| 17 | Term Exams | Textbooks |
Assessment (Exam) Methods and Criteria
| Assessment Type | Midterm / Year Impact | End of Term / End of Year Impact |
|---|---|---|
| 1. Midterm Exam | 100 | 40 |
| General Assessment | ||
| Midterm / Year Total | 100 | 40 |
| 1. Final Exam | - | 60 |
| Grand Total | - | 100 |
Student Workload - ECTS
| Works | Number | Time (Hour) | Workload (Hour) |
|---|---|---|---|
| Course Related Works | |||
| Class Time (Exam weeks are excluded) | 14 | 2 | 28 |
| Out of Class Study (Preliminary Work, Practice) | 14 | 2 | 28 |
| Assesment Related Works | |||
| Homeworks, Projects, Others | 1 | 0 | 0 |
| Mid-term Exams (Written, Oral, etc.) | 1 | 8 | 8 |
| Final Exam | 1 | 24 | 24 |
| Total Workload (Hour) | 88 | ||
| Total Workload / 25 (h) | 3,52 | ||
| ECTS | 4 ECTS | ||